The highly coordinated interactions of several molecular chaperones, including hsp70 and hsp90, are required for the folding and conformational regulation of a variety of proteins in eukaryotic cells, such as steroid hormone receptors and many other signal transduction regulators. The protein called Hop serves as an adaptor protein for hsp70 and hsp90 and is thought to optimize their functional cooperation. Here we characterize the assembly of the hsp70-Hop-hsp90 complex and reveal interactions that cause conformational changes between the proteins in the complex. We found that hsp40 plays an integral role in the assembly by enhancing the binding of hsp70 to the Hop complex. This is accomplished by stimulating the conversion of hsp70-ATP to hsp70-ADP, the hsp70 conformation favored for Hop binding. The hsp70-Hop-hsp90 complex is highly dynamic, as has been observed previously for hsp90 in its interaction with client proteins. Nonetheless, hsp90 binds with high affinity to Hop (K d ‫؍‬ 90 nM), and this binding is not affected by hsp70. hsp70 binds with lower affinity to Hop (K d ‫؍‬ 1.3 M) on its own, but this affinity is increased (K d ‫؍‬ 250 nM) in the presence of hsp90. hsp90 also reduces the number of hsp70 binding sites on the Hop dimer from two sites in the absence of hsp90 to one site in its presence. Hop can inhibit the ATP binding and p23 binding activity of hsp90, yet this can be reversed if hsp70 is present in the complex. Taken together, our results suggest that the assembly of hsp70-Hop-hsp90 complexes is selective and influences the conformational state of each protein.
Model systems for steroid hormone receptors, such as the progesterone and glucocorticoid receptors, have been critical to the study of the hsp90 chaperoning pathway (1) (2) (3) . These receptors can be isolated from the cell in a protein complex that contains the heat shock proteins, hsp90 1 and hsp70, two immunophilin proteins that bind the immunosuppressant drug FK506, FK506-binding proteins 52 and 51, and p23 (4). Studies to date have shown that these proteins do not interact in a simple association with the receptor but rather through a complex process, which involves ATP hydrolysis (5) (6) (7) (8) as well as other chaperone proteins, including hsp40 (9 -11) and Hop (9, 12 ). An in vitro chaperoning system has been developed that is capable of assembling a steroid receptor complex wherein the receptor has an active ligand binding domain. This system consists of five proteins (hsp40, hsp70, Hop, hsp90, and p23) and ATP (9, 10) .
A multistep model pathway for steroid receptor complex assembly has emerged (9, 11, (13) (14) (15) . The initiation of the pathway involves the binding of hsp40 to the receptor (11). This is followed by the binding of hsp70 to the receptor through an ATP-dependent mechanism. The receptor complex with hsp40 and hsp70 then assembles with Hop and hsp90 to form what has generally been referred to as the intermediate complex (16, 17) . This intermediate complex containing hsp70, Hop, and hsp90 is then converted to a mature complex containing hsp90 and p23, and at this stage the ligand binding domain of the receptor is properly folded so as to be able to bind hormone.
We were interested in examining in detail the components of the intermediate complex that is characterized by the binding of Hop to both hsp70 and hsp90 to make a three-component complex. Optimal hsp90 binding to steroid receptors occurs when a continuous supply of ATP is provided, as the activities of hsp90 are regulated by ATP binding and hydrolysis (6 -8) . When the drug geldanamycin binds to its ATP binding domain, hsp90 is unable to undergo conformational changes needed for its activities (18) . Similarly, when ATP is limiting, some hsp90 binding to receptors is lost, and no binding of immunophilins or p23 is observed. Under these conditions, most of the receptor is retained in the intermediate complex, bound to hsp70, Hop, and hsp90 (16) .
As its name (hsp-organizing protein) suggests, an important feature of Hop is that it will link hsp70 and hsp90 together (12) . Indeed, the binding of Hop to hsp70 and hsp90 occurs directly with pure proteins and without the need for ATP hydrolysis (19) . Hop alone does not possess any chaperone activity in protein refolding assays, unlike hsp70 and hsp90 (20, 21 ), yet Hop is nonetheless required for optimal receptor-hsp90 heterocomplex assembly (9, 22) .
Hop, hsp90, and hsp70 are present in a multiprotein complex in rabbit reticulocyte lysate (23) . The yeast homologue of Hop, STI1 (24) , is almost entirely complexed with hsp90 in similar hsp90 (hsp82)-Hop (STI1)-hsp70 (Ssa) complexes (25) . It has been further observed that all of Hop in rabbit reticulocyte lysate is immunoadsorbed with hsp90 (26, 27) . Hop contains several tetratricopeptide repeats (TPRs), protein motifs that have been shown to mediate specific protein interactions in numerous cellular contexts. Specifically, Hop has two TPR domains that have been implicated in its binding to hsp70 and hsp90. The N-terminal TPR1 domain binds to the C terminus of hsp70, and the central TPR2 domain binds to a TPR acceptor site in the C terminus of hsp90 (12, 28 -31) . In order to gain insights into the dynamics of hsp70 and hsp90 in the interme-diate complex, we sought to characterize the assembly of the hsp70-Hop-hsp90 complex. We examined the role of hsp40 in this process and found that it was integral to the assembly of this multichaperone complex. Also, the behavior of each protein appears to be influenced by interaction with the other proteins in this complex.
EXPERIMENTAL PROCEDURES
Materials-Mouse monoclonal antibody F5 was made against avian p60/Hop as described previously (23) . The F5 antibody cross-reacts with human Hop. Mouse monoclonal antibody JJ3 was prepared against human p23 as described previously (32) .
Protein Purification-A bacterial expression system for Ydj1 (accession number X56560) was generously supplied by Dr. Avrom Caplan and has been described previously (33) . Bacterial lysates were fractionated by DEAE-cellulose column chromatography followed by MonoQ FPLC and Superdex FPLC, as described previously (34) . The cDNA for human HDJ2 (accession number NM 001539) was generously supplied by Dr. Seishi Kato (35) . Bacterial lysates were fractionated by DEAEcellulose column chromatography followed by hydroxylapatite column chromatography and Superdex FPLC (34) . Human HDJ1 (36) (accession number P25685) was expressed in bacteria and purified as described for HDJ2. The cDNA for HDJ1 was generously supplied by Dr. Tobias Raabe. The amount of protein was routinely quantitated using Coomassie Plus Protein Assay reagent (Pierce).
Human hsp70 (accession number M11717) was overexpressed in baculovirus-infected Sf9 cells as described by Alnemri and Litwack (37) . Purification was performed as described previously (34) . Cell lysates were fractionated by DEAE-cellulose column chromatography followed by ATP-agarose column chromatography. The eluate was fractionated by MonoQ FPLC and then by Superdex 200 FPLC. Only the monomer peak of hsp70 was used. The preparation was ϳ97% pure as assessed by densitometry of SDS-PAGE gels.
Human Hop (accession number M86752) expressed in bacteria was prepared essentially as described previously (34) . Bacterial lysates were fractionated by DEAE-cellulose chromatography followed by hydroxylapatite column chromatography. Additional purification was achieved by fractionating the pool from hydroxylapatite on a Mono Q FPLC column that was eluted with a linear gradient of 0 -0.5 M KCl. The preparation was ϳ94% pure.
Human hsp90 ␤ (accession number M16660) was overexpressed in Sf9 cells and purified from cell lysates by DEAE-cellulose chromatography. Further purification was obtained with heparin-Sepharose chromatography, followed by MonoQ FPLC and Superdex FPLC, as described previously (6) . The preparation was ϳ99% pure.
The bacterial expression and purification of human p23 (accession number L24804) has been described (38) . The soluble fraction of the bacterial lysate was fractionated by DEAE-cellulose column chromatography followed by phenyl-Sepharose FPLC. The preparation was ϳ99% pure as assessed by densitometry of SDS-PAGE gels.
Experimental Conditions for Incubations-Antibody resin was prepared by incubating F5 or JJ3 antibody with a slurry of Protein ASepharose CL-4B (Amersham Biosciences) in 0.1 M potassium phosphate, pH 8.0, for 30 min at room temperature. The F5-or JJ3-conjugated resin was washed three times in incubation buffer (10 mM Tris-HCl, 50 mM KCl, 5 mM MgCl 2 , and 2 mM dithiothreitol, pH 7.5). Pellets of antibody resin (25 l) were suspended in 200 l of incubation buffer with other proteins added, as indicated. ATP or ADP were added where indicated at 5 mM. Where noted, an ATP regeneration system was included consisting of 10 mM phosphocreatine (di-Tris salt; Sigma) and creatine phosphokinase (3.5 units/100 l of lysate; type I, from rabbit muscle; Sigma). Untreated rabbit reticulocyte lysate was purchased from Green Hectares (Oregon, WI). Incubations at 30°C were done in heated water baths, with resuspension of the samples every 5 min. All samples were subsequently washed four times by centrifugation (at 4°C) and resuspension with 1 ml of incubation buffer without additional nucleotide or proteins. The samples were analyzed by SDS-PAGE on 7% gels. The SDS-PAGE gels were stained with Coomassie Blue. Images shown here were scanned using a digital camera.
Radiolabeled hsp90 and hsp70 Protein-[ 35 S]Methionine-labeled hsp90 was translated in vitro using the TnT system (Promega) with T7 RNA polymerase. For hsp90 binding analysis, each 200-l sample contained 1 l of translation solution with radiolabeled hsp90 and 10 g of unlabeled hsp90. [ 35 S]Methionine-labeled hsp70 was translated in vitro using the TnT system (Promega) with Sp6 RNA polymerase. For hsp70 binding analysis, each 200-l sample contained 1 l of translation solution with radiolabeled hsp70 and 20 g of unlabeled hsp70.
Quantification of Protein Levels-Arbitrary densitometric values for the indicated bands were obtained by using IP Lab Gel 1.5e software (Signal Analytics), which assigns a number corresponding to the pixel count in the area indicated. To quantify the amount of radiolabeled protein present, the proteins on the gel were transferred to a polyvinylidene difluoride membrane (Millipore Corp., Bedford, MA), and the level of radioactivity was measured using a Storm 840 PhosphorImager (Amersham Biosciences). The membrane was also Coomassie-stained to assess the total amount of protein bound, and this was compared with the amount of radiolabeled protein bound.
Calculation of Stoichiometry-Protein bands were quantified by densitometry to obtain an arbitrary number termed the "volume" after correcting for background binding. There is some degree of error in these measurements, because all proteins do not stain equally. To account for this, the amount of protein was quantitated using Coomassie Plus Protein Assay reagent (Pierce) from two independent assays each with two samples. Three micrograms of protein (Hop, hsp70, hsp90) were run on a 7% gel and Coomassie-stained. Densitometric values were obtained, and it was seen that hsp70 stains 1.3 times more than Hop, and hsp90 stains 1.2 times more than Hop. These numbers were taken as factors in the calculation of stoichiometry to normalize the amount of protein measured in the experiment. To measure the stoichiometry, the amount of hsp70 or hsp90 bound was compared with the total amount of Hop in those samples. The molar ratios were calculated using the following formulas. ATP-Sepharose Binding Assay-ATP-Sepharose binding assays were conducted as described previously (39, 40) . We used ␥-linked ATPSepharose with a 10-space linker (Upstate Biotechnologies, Inc., Lake Placid, NY). Purified hsp90 (10 g) was incubated with the proteins indicated in a final 200 l of incubation buffer plus 10 l of ATPSepharose for 30 min at 30°C with resuspension of the samples every 5 min. Samples were subsequently washed four times with 1 ml of incubation buffer by centrifugation (at 4°C) and resuspension. The samples were analyzed by SDS-PAGE on 7% gels. The SDS-PAGE gels were stained with Coomassie and scanned with a digital camera, and the bands were quantified. The sample containing only hsp90 was indicated as 100%, whereas the binding of hsp90 to the ATP-Sepharose under the conditions with the additional proteins (20 g of hsp70, 5 g of Ydj1, and increasing amounts of Hop, as indicated in the figure) was measured as a relative amount.
p23 Binding Assay-Pellets of JJ3 antibody resin (25 l) were suspended in 200 l of incubation buffer with 9 g of hsp90, 5 g of p23, 5 mM ATP, 20 mM sodium molybdate, and Hop and/or hsp70 as indicated. Samples were incubated at 30°C for 30 min to form complexes. Samples were subsequently washed four times with 1 ml of incubation buffer by centrifugation (at 4°C) and resuspension. The samples were analyzed by SDS-PAGE on 7% gels. The SDS-PAGE gels were stained with Coomassie Blue and scanned with a digital camera, and the bands were quantified.
RESULTS

Conditions for Binding of hsp90 and hsp70 to Hop-The
Hop chaperone complex consists of Hop, hsp70, and hsp90. This multiprotein complex can be isolated using an antibody resin specific for Hop, and we were interested in examining the general composition of this complex. Fig. 1A shows the protein content of Hop complexes, including the heavy chain (H-chain) of the anti-Hop antibody used for the immunoprecipitation. Purified Hop protein can be effectively immunoprecipitated using this system (lane 5). Further, as shown previously (23), there is a Hop complex that can be isolated from a heterogenous mixture of proteins, namely rabbit reticulocyte lysate, which consists of Hop and large amounts of both hsp90 and hsp70 (lane 1). This was compared with Hop complexes that were assembled using purified proteins to determine whether a similar pattern would be seen. We used an in vitro five-protein chaperone system containing hsp40, hsp70, Hop, hsp90, and p23. The hsp40 protein Ydj1 was used here. This yeast protein contains all of the functional domains of bacterial DnaJ and is thus a type I homologue of DnaJ (41) . It is highly homologous to HDJ2, a human hsp40 protein, which functions interchangeably with Ydj1 in our in vitro PR system (11) . This five-protein system has been central to the study of the hsp90 chaperoning pathway (9, 11) . These proteins have been extensively studied in a model system using the avian progesterone receptor (PR), which has a hormone binding domain that is very unstable and rapidly loses its binding activity at elevated temperatures (16) . However, the hormone binding ability can be restored by using the five-protein chaperone system with ATP. When the five proteins were incubated in the absence of the PR substrate, they were able to form a Hop complex similar to that from rabbit reticulocyte lysate. This occurred both with ATP (lane 2) and without ATP (lane 3), yet there was more binding of hsp70 to Hop in the absence of ATP. The proteins were indeed binding specifically to Hop, since an immunoprecipitation from a sample with hsp40, hsp70, hsp90, and p23, but without Hop, showed no nonspecific binding (lane 4).
To gain more insight into the assembly of the Hop complex, we wanted to look in detail at hsp70 and hsp90 binding to Hop without any accessory proteins, as seen in Fig. 1B . When Hop, hsp70, and hsp90 are present, there is considerable hsp90 binding to Hop both in the presence (lane 1) and absence of ATP (lane 2). There is some hsp70 binding to the complex, but it is relatively low in abundance, especially when compared with the amount present in the more complex system seen in Fig.  1A . Nonetheless, without accessory proteins, the hsp90 is potentiating the binding of hsp70 to Hop, given that there is more hsp70 bound to Hop in the presence of hsp90 (lanes 1 and 2) than in the absence of hsp90 (lanes 6 -8) . It can also be seen that hsp90 binds to Hop in the absence of hsp70 as well as in its presence. This binding is the same whether in the presence of 5 mM ATP (lane 3), no nucleotide (lane 4), or 5 mM ADP (lane 5). In contrast, hsp70 does not bind well to Hop without any other proteins present. When Hop and hsp70 were incubated with 5 mM ATP (lane 6), no binding of hsp70 was observed, confirming the inhibitory effect of ATP reported earlier (19) . There was a very low level of hsp70 binding when no nucleotide was present (lane 7) and slightly more in the presence of 5 mM ADP (lane 8). These levels of hsp70 were nonetheless extremely low, especially when compared with the hsp70 binding to Hop in the presence of accessory proteins as was shown in Fig. 1A .
The Binding of hsp70 to Hop Can Be Enhanced by hsp40 -The requirements for the binding of hsp70 to Hop were not satisfied with varying nucleotide conditions, so we hypothesized that an accessory protein may be playing a role in facilitating this interaction. It has been observed that hsp40 binds to the ATPase domain of hsp70 and stimulates its ATP hydrolysis activity (42) (43) (44) (45) , which is needed for high affinity binding of hsp70 to substrates. We thus tested the effect that hsp40 may have on the formation of the Hop complex, as is seen in Fig. 2A . In this experiment, purified Hop protein was effectively immunoprecipitated (lane 1), and the proteins tested bound specifically to Hop, since an antibody resin with hsp40, hsp70, and hsp90, but without Hop, showed very little nonspecific binding (lane 2). As had been observed previously, there were extremely low levels of hsp70 binding to Hop in the absence of nucleotide or other proteins (lane 3). However, when hsp40 was present, considerable hsp70 binding to Hop in the absence of hsp90 was observed (lane 4). This effect was also seen in the presence of hsp90, since low levels of hsp70 binding were seen without hsp40 (lane 5) and high levels were seen with hsp40 (lane 6). Whereas hsp40 is playing a role in the binding of hsp70 to Hop and the assembly of the hsp70-Hophsp90 complex, it is not binding directly to the Hop complex at a level that can be appreciated with Coomassie Blue staining. This implies that hsp40 interacts with the hsp70 only transiently during the assembly process.
In the initial observation of the effect of hsp40, Ydj1 was used as the hsp40. Since the other chaperone proteins in our system are of human origin, it remained a possibility that HDJ2 could function more effectively than Ydj1 in this system. Further, the examination of HDJ1, a human hsp40 protein with less homology to Ydj1 than HDJ2, might also lead to some insights into the domain requirements of this interaction with hsp70 in the context of binding to Hop. Studies in yeast (46) have shown that among three human hsp40 homologues as- Importantly, all three of these hsp40 proteins share a similar J domain, a region of hsp40 that has been shown to interact directly with hsp70, and this domain could be playing a critical role in assisting the binding of hsp70 to Hop.
In other studies, when hsp40 was shown to stimulate the ATP hydrolysis activity of hsp70, it was observed that this could occur even when hsp40 is at substoichiometric levels (41) . As such, we were interested in examining how much hsp40 was needed for hsp70 to bind to Hop and seeing whether this was a similar situation to that of ATP hydrolysis or whether this function instead required stoichiometric levels of hsp40. A titration of hsp40 levels is shown in Fig. 3A . Low levels of hsp70 binding were observed when 0.1 g of hsp40 or less was added (lanes 1-3) . However, optimal binding of hsp70 to Hop could be seen with levels as low as 0.5 g of hsp40. With higher amounts of hsp40 (lane 5 and data not shown) up to 15 g, similar levels of hsp70 were observed, indicating that this was the maximal level of hsp70 binding that could be observed under these conditions. The concentration of hsp70 was 1.4 M, whereas the concentration of hsp40 at the lowest level of hsp40 needed for maximal binding of hsp70 to Hop (lane 4) was 0.06 M. This indicates that hsp40 can function at markedly substoichiometric levels to assist hsp70 in binding to Hop. This is strikingly similar to the case in a luciferase refolding system consisting of purified hsp70, hsp90, and Ydj1, where it was seen that the amount of luciferase renatured was maximal when the Ydj1 concentration was approximately a ratio of 1 molecule of Ydj1 to 20 molecules of hsp70 (34) . Similar results have been shown for assembly of progesterone receptor complexes (9) . This low stoichiometry observed in Fig. 3A further implies a dynamic system in which the hsp40 interacts with hsp70 only briefly during multichaperone complex assembly.
Whereas it was observed that the amount of hsp40 required to get maximal binding of hsp70 to Hop was low, it was not clear whether there would be any effect with higher levels of hsp40. In Fig. 3B , we looked at the rate of hsp70 binding to Hop and compared three levels of hsp40 that were all above the minimal levels seen to be required in Fig. 3A . Under all of these conditions, the same level of hsp70 binding is reached, and this occurs in less than 30 min. However, the rate at which maximal binding is achieved differs, depending on how much hsp40 is (47) . The binding and release of the substrate are directed by ATP and ADP, which dictate the conformational state of the chaperone. hsp70 binds substrate loosely when there is ATP bound and tightly after hydrolysis of ATP to ADP (48, 49) . Previous studies indicated a preference for Hop binding to hsp70 in its ADP-bound conformation (19) . We were particularly interested in viewing the effects of nucleotides with regard to levels of hsp40, given that this protein stimulates the ATP hydrolysis activity of hsp70. As seen in Fig. 4 , when no ATP is present, hsp70 binds well to Hop with either 1 g of hsp40 (lane 1) or 5 g of hsp40 (lane 2). This is the same binding observed at 5 M ATP and 10 M ATP for both 1 g of hsp40 (lanes 3 and 5) and 5 g of hsp40 (lanes 4 and 6) . However, at 50 M ATP and 100 M ATP, hsp70 binding to Hop is considerably reduced when only 1 g of hsp40 (lanes 7 and 9) is present. This is overcome, however, when 5 g of hsp40 (lanes 8 and 10) are present. This indicates that increasing amounts of ATP decrease the binding of hsp70 to Hop. Nonetheless, when enough hsp40 is present, these inhibitory levels of nucleotide can be overcome, presumably through ATP hydrolysis to produce hsp70-ADP.
hsp90 and hsp70 Interact Dynamically with Hop-We sought to examine the stability of the interaction between hsp90, hsp70, and Hop. First, the dynamics of hsp90 in the hsp70-Hop-hsp90 complex were assessed under different conditions by measuring the dissociation of bound hsp90 from the complex after the removal of free hsp90 as well as the exchangeability of bound hsp90 with free hsp90. The hsp70-Hop-hsp90 complex was assembled with [
35 S]Met-labeled hsp90 during the first incubation. These samples were washed to remove the free radiolabeled hsp90 not bound to the complex. In the dissociation experiments, no hsp90 was added in the second incubation; in the exchange experiments, unlabeled hsp90 (in a 4-fold excess) was added in the second incubation. In the protein complexes isolated from the exchange experiments, the total bound hsp90 levels (radiolabeled plus unlabeled) were constant throughout the time course, as seen by Coomassie Blue staining (data not shown). This indicates that the hsp90-Hop complex remained saturated with hsp90 and that any loss of radiolabeled hsp90 occurred by exchange with unlabeled hsp90. The extent to which this occurred was measured by observing how much radiolabeled hsp90 remained after a given time. The stability of the binding of hsp70 to the hsp70-Hop-hsp90 complex was done in the same way as the hsp90 experiments, except radiolabeled hsp70 was used instead of radiolabeled hsp90.
A graph of the time course of hsp90 dissociation and exchange is shown in Fig. 5A , with the closed circles corresponding to the progress of dissociation after the removal of free hsp90 and the open circles representing the extent of exchangeability. The closed circles illustrate the dissociation of hsp90 from the hsp90-Hop complex when it was subsequently incubated at 30°C in buffer alone. The amount of radiolabeled hsp90 bound to Hop under these conditions stayed relatively constant, with ϳ70% remaining after a 10-min incubation at 30°C. These dissociation data show that, under the conditions assayed, there is no marked loss of the complex, and they are in line with the idea that this is a high affinity interaction with little net dissociation under the conditions used. Nonetheless, there is considerable exchange of hsp90 from the hsp70-Hophsp90 complex, and this occurs rapidly. By 2 min of incubation, more than 50% of the hsp90 has been exchanged with unlabeled hsp90. The final level of exchangeability observed corresponds to the hsp90 reaching background levels or having fully exchanged within this time frame, given that the radiolabeled hsp90 was only diluted 4-fold with unlabeled hsp90 in the second step.
The dissociation and exchange of hsp70 from a hsp90-Hop complex was also measured, and this is seen in Fig. 5B . This is also a highly dynamic interaction that is observed under these conditions, as was seen with hsp90 and Hop. As with hsp90, by 2 min of incubation, ϳ50% of the radiolabeled hsp70 that was bound remained. Between 5 and 10 min of incubation, only background levels of radiolabeled hsp70 were observed. However, in contrast to hsp90 in Fig. 5A , there was a high level of dissociation of hsp70 from the complex, which could also account for the loss under exchange conditions. This implies that the interaction of hsp70 with Hop is of lower affinity than that of hsp90.
The Binding of hsp90 to Hop- Fig. 5 suggested that there might be a difference in the affinity of hsp90 and hsp70 for Hop, so we examined this possibility in more detail. Since hsp90 is able to bind Hop in the absence of other proteins, its binding was measured throughout a range of concentrations (0.03-1.8 M) and expressed in a Scatchard plot (Fig. 6A) . It was observed that hsp90 binds tightly to Hop with a K d equal to 90 nM. In our studies (Fig. 1B) , it was observed that hsp70 did not have an effect on the amount of hsp90 that could bind to Hop, and this was true whether in the absence of nucleotide or with 5 mM ATP. We wanted to examine whether hsp70 would affect the high affinity interaction of hsp90 to Hop. Several conditions were tested including those where hsp70 had been shown not to bind to the Hop complex (no hsp40 both plus and minus 5 mM ATP) and those conditions favorable for hsp70 binding (with hsp40 both plus and minus 5 mM ATP). None of these conditions significantly affected the affinity of hsp90 for Hop, given that the K d observed fell into a range between 80 and 95 nM. This is very similar to the affinity observed when hsp90 alone bound to Hop, indicating that hsp70 does not influence the The Binding of hsp70 to Hop-We had observed that there might be a slight effect of hsp90 on the binding of hsp70 to Hop in the absence of hsp40 (Fig. 1B) . We were interested to see whether hsp70 bound to Hop with the same affinity as hsp90 and whether hsp90 affected the binding of hsp70. The affinity of hsp70 for Hop was measured under optimal conditions, without ATP and in the presence of hsp40 (Fig. 7) . The binding affinity was much lower than that for hsp90 and Hop with a K d equal to 1.3 M. However, whereas hsp70 did not influence the binding of Hop to hsp90, hsp90 dramatically enhanced the binding of hsp70 to Hop by 5-fold to a K d equal to 250 nM. hsp90 also restricted the number of hsp70 binding sites on Hop. However, similar to the binding of hsp90 to Hop, the Scatchard analysis for the binding of hsp70 to Hop showed a linear relationship consistent with a single type of binding interaction in the presence and absence of hsp90. In order to gain more insight into the protein composition of the Hop complex, we examined the stoichiometry of the proteins in the hsp70-Hop and the hsp70-Hop-hsp90 complexes in more detail (Fig. 8) . Titrations of hsp70 binding to Hop both in the presence and absence of a saturating level of hsp90 were used to determine the saturating amounts of chaperone proteins. The amounts of hsp70 and hsp90 bound were compared with the total amount of Hop in those samples. From these values, the molar ratios were calculated at different concentrations of hsp70 both in the presence and absence of hsp90 (see "Experimental Procedures"). The molar ratio of hsp70 to Hop, as monomers, is about 1:1 at saturating conditions. However, in the presence of hsp90, the molar ratio of hsp70 to Hop is about 0.5:1 at saturating conditions, showing that hsp90 reduces the number of binding sites that are available for hsp70 binding to about half. Nonetheless, the molar ratio of hsp90 to Hop is about 1:1 at all levels of hsp70 assayed. This indicates that hsp70 does not markedly influence the stoichiometry of hsp90 to Hop, since it did not influence its affinity (Fig. 5) . Previous studies have shown that Hop (50) and hsp90 (51) function as homodimers, whereas hsp70 has been observed to be a monomeric protein (52) , since it appears to be present in Hop complexes. Our results support a model where one dimer of Hop binds one hsp90 dimer and one hsp70 monomer.
hsp70 Reverses the Hop Inhibition of hsp90 ATP Binding Activity-Whereas we had observed that hsp90 influenced the binding affinity and stoichiometry of the interaction between hsp70 with Hop, hsp70 did not have an analogous effect on the interaction between hsp90 and Hop. As such, we were interested in determining whether the presence of hsp70 in the hsp70-Hop-hsp90 complex would have a functional influence on hsp90. Specifically, we examined the influence on the ability of hsp90 to bind ATP. It has been observed that the yeast homologue of Hop, Sti1, inhibits the ATP hydrolysis activity of hsp90 and also blocks the binding of geldanamycin at the ATP binding site near the N terminus (50) . Thus, hsp90 bound to Hop is apparently restricted to a conformation that lacks ATP interaction. In our study, we compared the effect of Hop on the ability of hsp90 to bind ATP both in the presence and absence of hsp70, as is seen in Fig. 9 . We took advantage of a 10-carbon linker ␥-linked ATP-Sepharose to which hsp90 can readily bind, yet hsp70 binds it only at low levels under our assay conditions (data not shown). We measured the binding of hsp90 to the ATP-Sepharose in the absence of other proteins (lane 1), and a high level of hsp90, corresponding to most of the protein added, was pulled down in our assay. This level of binding was designated as 100%, and the subsequent levels of hsp90 were measured as relative amounts. When hsp70 and hsp40 were added with the hsp90 (data not shown), the levels of hsp90 were roughly equivalent to those in their absence, indicating that hsp70 and hsp40 did not affect the binding of hsp90 to ATP-Sepharose in our assay. When Hop was added in increasing amounts (lanes 2-4) , the levels of hsp90 binding to ATP were reduced, consistent with previous studies (50) . However, when hsp70 and hsp40 were also added to hsp90 with increasing amounts of Hop (lanes 5-7) , this inhibitory effect of Hop was reversed, as high levels of hsp90 binding to ATP-Sepharose were observed. These results reveal a role for hsp70 in the hsp70-Hop-hsp90 complex. hsp70 may serve to influence the conformation of Hop in its interaction with hsp90 such that the ATP binding site of hsp90 is no longer blocked by Hop. An alternative possibility is that Hop mediates a direct interaction between hsp70 and hsp90 that, in turn, influences the conformation of hsp90 to enable hsp90 to bind nucleotide.
hsp70 Reverses the Hop Inhibition of hsp90 p23 Binding Activity-It has been seen that the conformation of hsp90 is altered upon binding of ATP to a form that is capable of binding its cochaperone p23 (39, 53) . Also, distinct conformations of hsp90 are required for Hop and p23 binding so that these two proteins are not bound to hsp90 at the same time (19) . Therefore, we were interested in examining how the effect of the hsp70-Hop-hsp90 complex on ATP binding related to the ability of hsp90 to bind its cochaperone p23. In the experiments shown in Fig. 10 , the binding of p23 to hsp90 was promoted by incubation at 30°C with 5 mM ATP and 20 mM sodium molybdate. Molybdate stabilizes and enhances the yield of p23-hsp90 complex (54) . The amount of complex adsorbed to antibody resin was then resolved by SDS-PAGE (Fig. 10A ) and quantitated by densitometry (Fig. 10B) . We observed that when p23 and hsp90 are incubated with increasing amounts of Hop, the binding of hsp90 to p23 is inhibited in a dose-dependent manner. However, when p23 and hsp90 are incubated with increasing amounts of Hop, yet also in the presence of hsp70 and hsp40, the inhibition by Hop is overcome, and hsp90 binds to p23. The amount of binding of p23 to hsp90 in the presence of Hop and hsp70 is the same as that in the absence of Hop (Fig. 10A, lanes  1 and 7) or with only hsp90 and p23 present (data not shown). Note that very little Hop or hsp70 exists in the p23-hsp90 complexes (Fig. 10A) . Apparently, hsp90 in the complex with Hop and hsp70 is able to bind ATP, and this leads to an hsp90 conformation that lacks Hop interaction but is able to bind p23. This is further evidence that hsp90 in the hsp70-Hop-hsp90 chaperone complex is functionally distinct from hsp90 in a Hop-hsp90 complex.
DISCUSSION
The highly coordinated interactions of several molecular chaperones, including hsp70 and hsp90, are required for the folding and conformational regulation of a variety of proteins in eukaryotic cells, such as steroid hormone receptors and many other signal transduction regulators (14, (55) (56) (57) (58) . The protein Hop, also called p60 or Sti1, serves as an adaptor protein for hsp70 and hsp90 (59) and is thought to optimize their functional cooperation, despite the fact that Hop does not have any measurable chaperoning activity on its own (20, 21) . Hop (Sti1) is not an essential protein in yeast, but its deletion clearly reduces the functioning of steroid receptors in yeast model systems (60) . In vitro, Hop has been shown to be necessary for optimal chaperoning of hsp90 client proteins such as the glucocorticoid and progesterone receptors (9, 61) and the reverse transcriptase of hepatitis C virus (62) . In this pathway, wherein the receptor is chaperoned to a conformation that is capable of binding hormone, PR first forms a complex with hsp40 and hsp70 (11) . This PR complex then assembles with Hop and hsp90 to form what has generally been referred to as the intermediate complex (16, 17) . Although hsp90 is a part of this complex, the receptor is still unable to bind hormone, since this occurs when the intermediate complex is converted to a mature complex containing bound p23.
Previous studies have suggested that the proteins studied here constitute a chaperone machine or "foldosome" (14) that is highly dynamic and may vary in composition according to what step in the chaperoning process it is involved in at any particular time. It has been seen in other studies that hsp40 is a component of the hsp90-Hop-hsp70 foldosome complex isolated from rabbit reticulocyte lysate with antibody against Hop (10), although we did not see that in our studies. Here, we have concentrated on the study of a purified protein system.
Through two separate domains, Hop can bind to both hsp70 and hsp90 simultaneously, and it is believed to act as an adaptor to promote the binding of hsp90 to preexisting early PR complexes (23, 59, 63) . We looked in detail at the hsp70-Hophsp90 complex under conditions independent of a client protein substrate such as the progesterone receptor. Our results indicate that Hop interacts differently with hsp70 and hsp90 in the complex. We propose three reactions that should take place in the cell leading to the assembly of hsp70-Hop-hsp90 complexes, as shown in Fig. 11 . These reactions agree with previous models of the hsp90 chaperoning pathway while adding more detail to the individual and collective interactions of hsp70 and hsp90 with Hop. The results also point out a novel role for hsp40 in the assembly of the hsp70-Hop-hsp90 complex.
In regard to reaction 1 in our proposed model (Fig. 11) , it has been seen that a majority of the Hop in rabbit reticulocyte lysate is bound to hsp90 (26, 27) , and this is consistent with the high affinity interaction observed with the purified proteins. This affinity (K d ϭ 90 nM) is substantially higher than that measured previously with calorimetric isothermal titration using 12-mer peptides for sequences corresponding to the interaction sites between Hop and hsp90 (31) . In that study, the affinity between Hop and hsp90 (K d ϭ 6 M) may have been lower than the one we measured, because the affinity was only between the two peptides, as opposed to the full-length proteins that were used in our study. This suggests that there may be other regions of Hop and/or hsp90 that are bound or modified upon their interaction with each other and with hsp70 and hsp40 that may increase their affinity for one another.
The interaction between Hop and hsp90 does not depend on nucleotide to form (Fig. 1B) . Further, both Hop (20, 50) and hsp90 are known to be dimeric (51) , and our results indicate that they interact with each other as dimers. Importantly, the interaction between Hop and hsp90 is a highly dynamic one (Fig. 6 ). This high affinity interaction involves rapid dissociation and reassociation of the proteins (Fig. 5A ). In the cell, both hsp90 and Hop are abundant proteins. Yet, hsp90 exists at higher concentrations than Hop, and thus it is likely that essentially all of the Hop is in a complex with hsp90.
The binding of hsp70 to Hop is distinct from that of hsp90 and Hop. In contrast to hsp90, there is a dramatic inhibitory influence of ATP on this binding (Fig. 1B) . Further, since hsp70 has a high affinity for ATP, its prevalent form in cells is likely to be hsp70-ATP. Thus, hsp40 plays an essential role in facilitating the hsp70-Hop interaction as shown in reaction 2 (Fig.  11) . It is the J domain of hsp40 that plays a critical role (Fig.  2B) , although it is not known from these studies whether it is both necessary and sufficient. The binding of purified hsp70 to Hop is influenced by hsp40 even in the absence of added ATP. However, ATP-agarose affinity chromatography is a key purification step that results in the saturation of hsp70 with ATP, and this bound nucleotide must be dissociated or hydrolyzed before the hsp70 is able to bind Hop. In the cell, there may be very little free hsp70 in the ADP-bound state, but this would be generated when hsp70 is involved in chaperoning substrate proteins. As such, the ATP hydrolysis activity of hsp70 can be stimulated by either interaction with hsp40 or with the substrate protein or most likely by both.
In the final step of hsp70-Hop-hsp90 complex formation, the prevalent complex of hsp90-Hop would bind the less prevalent hsp70-ADP, as shown in reaction 3 (Fig. 11) . It seems unlikely that hsp70 would bind separately to Hop alone because of the lower affinity of this interaction and the low abundance of free Hop. It is this three-protein complex, hsp70-Hop-hsp90, that has been observed in rabbit reticulocyte lysate (23) as well as in yeast (25) . Our studies indicate that Hop not only bridges the interaction between hsp90 and hsp70 but may indeed also change conformation during this assembly process. These structural changes are suggested by the fact that both the affinity and stoichiometry of hsp70 to Hop are influenced by the binding of hsp90. We observed that the binding of hsp70 to Hop is enhanced 5-fold by the presence of hsp90. Thus, it is likely that hsp90 alters the conformation of Hop to increase its affinity for hsp70. An alternative possibility is that the bound hsp90 also provides contact sites for hsp70 binding. We have not observed any binding of hsp90 to hsp70 directly, in the absence of Hop. However, such an interaction has been suggested by chemical cross-linking studies (27) and has been observed directly with proteins from neurospora (64) .
It is very interesting to look at our results in the context of what is known about Hop domain structure, particularly in how it relates to hsp70 and hsp90 binding. Hop contains multiple TPRs, with separate TPR domains determining its binding to hsp70 and hsp90. TPR domains are protein motifs that are composed of loosely conserved 34-amino acid sequences that are repeated anywhere from 1 to 16 times per domain. TPR protein domains were originally identified in components of the anaphase-promoting complex (65, 66) . Since then, TPR domains have been shown to mediate specific protein interactions in numerous cellular contexts (67) . The highly conserved structure of the TPR fold is consistent among a number of x-ray structures of different TPR domains (67) . Each motif forms a pair of antiparallel ␣-helices. These structures are further arranged in a tandem array to form a superhelical structure that encloses a central groove (67) .
Hop contains three TPR domains, each composed of three TPR motifs (31) . The N-terminal TPR domain, called TPR1, has been specifically implicated in the interaction with hsp70 (12, 28, 68) . In contrast, two regions of Hop spanning the middle and C-terminal domains, called TPR2A and TPR2B, have been shown to be critical for the interaction with hsp90 (12, 50) . Deletion mutagenesis has suggested that the C-terminal se- quence motif, which is highly conserved in all hsp70s and hsp90s of the eukaryotic cytosol, has an important role in TPR-mediated cofactor binding (28 -30, 43, 69, 70) . In fact, TPR1 specifically recognizes the C-terminal seven amino acids of hsp70 (PTIEEVD), whereas TPR2A recognizes the C-terminal five residues of hsp90 (MEEVD) (31, 71) . There is some overlap in the recognition sites for hsp70 and hsp90 on Hop, at least when using peptide fragments of the proteins (72) . This supports a model wherein there may be some hsp70 binding to the hsp90 site on Hop in the absence of hsp90, a situation which may or may not have physiological significance.
There are two possibilities for the extra hsp70 binding to Hop that is observed in the absence of hsp90. First, hsp70 could be binding to the hsp90 site on Hop. In the absence of hsp90, hsp70 may have been able to bind to the TPR2 region normally reserved for hsp90, albeit with a relatively lower affinity than hsp90 binding, yet when hsp90 is present that site is no longer available for hsp70 binding. Second, since Hop is a dimer (50) , there may be two sites for hsp70, but one is conformationally altered by hsp90 binding. The idea of interdomain interaction in Hop has been suggested before in the context of mutations in C-terminal DP motif of Hop that disrupt the interaction with hsp70 (59) . Our data suggest that the binding of the hsp90 to the TPR2A and TPR2B domains influences the conformation of the TPR1 domain to enhance the binding of hsp70 to Hop by increasing its affinity yet reducing the contact areas where hsp70 is able to bind. This provides additional selectivity for hsp70 binding to Hop-hsp90, not to Hop alone.
In applying the reactions in Fig. 11 to the assembly of hsp90 with client protein, we propose the initial recognition of client protein by hsp40 and then hsp70 as shown previously for PR (11) , and this would then readily associate with hsp90-Hop (from reaction 1) to form a client protein complex with hsp70(ADP)-Hop-hsp90 (and probably hsp40) according to reaction 3. Whether client protein complexes in the cell form from separate components as in reaction 3 or from preformed "foldosome" complexes (14) or both remains unknown. A key to understanding the mechanisms that control chaperone activity in this complex is provided by our results on the functional change in hsp90 when going from the state in reaction 1 to reaction 3. hsp90 bound with Hop is unable to bind ATP, lacks ATP hydrolysis activity (50) , and is perhaps a relatively inert chaperone until it can associate with hsp70 bound to client protein. However, when this happens, the inhibitory influence of Hop is relieved although Hop remains associated with hsp90. This transformation of hsp90 may also enhance its ability to bind to the client protein, since previous studies indicate that free hsp90 or Grp94 bind rather poorly to proteins or peptides (73) (74) (75) . The binding of ATP to hsp90 then results in a new conformation that can bind p23 and dissociate from Hop. Thus, the interplay between the proteins in the hsp70-Hop-hsp90 complex and ATP would appear to be key factors in dictating the sequence of events in the chaperoning of hsp90 client proteins.
Indeed, protein-protein interactions dictate the conformation and functional capacity of each protein in the hsp70-Hop-hsp90 complex. As such, Hop functions as a mediator for conformational changes and is doing more than simply bringing hsp70 and hsp90 together as many models have previously suggested.
